Full dossier in preparation
Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.
Process with priority
Sign in free to move this company to the front.
Summary
Conclusion
the dossier summarised in one paragraphHospidex Group is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2024 annual accounts show equity of €22.80M and a net result of €-72k. Equity is growing by ~7.9% per year across the filed fiscal years. Its solvency ranks better than 60% of 678 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 3 annual accounts.
Filing behaviour
From the deposit records, complete market-wideDeadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 12 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 24-07-2025, 7 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 31-12-2025 | 31-07-2026 | nothing on record | not filed | - |
| 31-12-2024 | 31-07-2025 | 24-07-2025 | 7 d early | 2025-00302095 |
| 31-12-2023 | 31-07-2024 | 03-07-2024 | 28 d early | 2024-00215425 |
| 31-12-2022 | 31-07-2023 | 13-07-2023 | 18 d early | 2023-00252033 |
Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Trust signals
2 signalsMore than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyoneThis is a financial institution (bank, insurer or financial holding). Our bankruptcy model is trained on ordinary trading and manufacturing companies; a bank balance sheet falls outside that scope. We therefore show no bankruptcy probability rather than a misleading figure.
Financials
Equity€22.80M-0.3%
Net result€-72k+46.9%
Total assets€39.31M+2.2%
Solvency58.0%-1.5pp
Annual accounts & ratios
Source: NBB · 2024Annual accounts filed on 24-07-2025 with the NBB · fiscal year 2024 · volledig
The figures below are the statutory (non-consolidated) annual accounts. This company also files consolidated accounts; the group figures can differ substantially.
No trend projection for this company: it files both statutory and consolidated annual accounts. The statutory figures above track the parent, and they jump when activities move inside the group, not when the business grows or shrinks. A trend through such a series measures a restructuring, not a business trajectory.
Sector comparison
Fiscal year 2024 · NACE 64, Financial services · compared within the same schema type (full schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 58.0% | 44.9% | |
| Net result | €-72k | €48k | |
| Equity | €22.80M | €1.36M | |
| Staff costs | €129k | €197k | |
| Employees (FTE) | 1.0 | 1.4 |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
P60
Stable position over 2022-2024
· n=412-678
P18
Stable position over 2022-2024
· n=412-677
P80
Stable position over 2022-2024
· n=412-678
P41
Improving position over 2022-2024
· n=121-164
Describes the position versus peers, not a forecast.
€-72k
+46.9%
22-24
€39.31M
+2.2%
22-24
€22.80M
-0.3%
22-24
1
0.0%
22-24
€129k
+1.7%
22-24
€-9k
-
22-24
€16.51M
+5.9%
22-24
€6.18M
+44.6%
22-24
€10.11M
-9.8%
22-24
58.0%
-2.5%
22-24
-0.3%
+46.8%
22-24
-0.2%
+48.1%
22-24
Figures by fiscal year
| Fiscal year | 2024 |
|---|---|
| Deposit | volledig |
| Revenue | n/a |
| EBITDA | n/a |
| Net profit | €-72k |
| Cash flow | n/a |
| Staff costs | €129k |
| Income taxes | €-9k |
| Dividends | - |
| Total assets | €39.31M |
| Equity | €22.80M |
| Debt | €16.51M |
| of which ≤ 1y | €6.18M |
| of which > 1y | €10.11M |
| Working capital | n/a |
| Employees (FTE) | 1.0 |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | n/a |
| Quick ratio | n/a |
| Working capital ratio | n/a |
| Solvency | 58.0% |
| Debt / equity | n/a |
| Long-term debt ratio | n/a |
| Interest coverage | n/a |
| Gross margin | n/a |
| Net margin | n/a |
| ROA | -0.2% |
| ROE | -0.3% |
| EBITDA margin | n/a |
| Days sales outstanding | n/a |
| Days payable outstanding | n/a |
| Inventory turnover | n/a |
| Days inventory (DSI) | n/a |
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €39.31M |
| Fixed assets | 21/28 | €37.36M |
| Formation expenses | 20 | €0 |
| Tangible fixed assets | 22/27 | €390k |
| Financial fixed assets | 28 | €36.97M |
| Current assets | 29/58 | €1.94M |
| Amounts receivable within one year | 40/41 | €880k |
| Cash & bank | 54/58 | €908k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €39.31M |
| Equity | 10/15 | €22.80M |
| Contributions / capital | 10/11 | €23.07M |
| Accumulated profits (losses) | 14 | €-275k |
| Amounts payable | 17/49 | €16.51M |
| Amounts payable after one year | 17 | €10.11M |
| Amounts payable within one year | 42/48 | €6.18M |
| Trade debts payable within one year | 44 | €477k |
| Income statement | ||
| Turnover | 70 | €1.65M |
| Operating result | 9901 | €430k |
| Financial income | 75 | €3k |
| Financial charges | 65 | €515k |
| Result before taxes | 9903 | €-81k |
| Income taxes | 67/77 | €-9k |
| Net result for the period | 9904 | €-72k |
| Result to be appropriated | 9905 | €-72k |
You're seeing the latest fiscal year only. Unlock 2 prior years (figures + ratios) with a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2024 · computedModel not applicable to financial institutions
The health score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here.
Directors
Directors & mandates
4 directorsCurrent directors & mandates
-
Five Stars InvestLegal entityDirector· perm. rep.: Yves PauwelsState Gazette act 24174421 (11-12-2024)Current05-07-2024 → present
-
Amos BVLegal entityManaging director· perm. rep.: Hendrik SeghersState Gazette act 21070082 (14-06-2021)Current19-03-2021 → present
-
Consulit BVLegal entityManaging director· perm. rep.: Francis GielenState Gazette act 21070082 (14-06-2021)Current19-03-2021 → present
-
Mithos BVLegal entityDirector· perm. rep.: Bart CaubergheState Gazette act 21070082 (14-06-2021)Current19-03-2021 → present
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Statutory auditor
2 auditors| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| BDO Bedrijfsrevisoren Burg.CVBACurrent Statutory auditor · represented by Gert Maris |
- | 06-05-2022 → present |
| BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES Company auditor · represented by Gert MARIS succeeded by BDO Bedrijfsrevisoren Burg.CVBA in 2022 |
- | 19-03-2021 → 06-05-2022 |
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Insolvency mandates
No insolvency mandates (liquidators, administrators) on record for this company.
Legal Structure
| NACE primary | Activiteiten van holdings(64210) |
| Legal form | Private limited company(610) |
| Incorporation | 10-03-2021 |
| Status | Active |
| Postal code | 3300 |
Structure & network
Connections & network
7 connected companiesGroup structure
Sits on the board · 1 subsidiary · 1 location
Control→
We sit on their board · 1 location
→
We sit on their board · 1 location
→
Network connections
Shared address
→
Shared address
→
Shared address
→
Shared address
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Ownership & control
3 partiesControl over this companysits on this company's board1
1 subsidiary · 1 location
controls
Hospidex GroupBE 0764.882.018
controls
Where this company holds controlthis company sits on their board2
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Locations & real estate
Registered office
on the map · from the address registerEstablishment units
1 locationHospidex Group
since 20212.317.710.080
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area6,161 m²
Buildings1
Building footprint2,440 m²
Volume (LiDAR)20,225 m³
Tallest building11.4 m · ±3 fl.
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24592F0056/00L000 | Flanders | 6,161 m² | 1 · 2,440 m² | 11.4 m · 3 fl. |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgisch Staatsblad · acts
12 acts Capital history · 5
30-10-2025
v3.2
10-05-2023
v3.2
02-09-2022
v3.2
13-01-2022
v3.2
14-06-2021
v3.2
Address history · 1
25-03-2021
v3.2
All acts · 12
updated 1 month ago
2026
15-06-2026 Merger · Accounting effect · Power of attorney · Soil certification
- Filing: 2026-06-05 · INNOMEDIQ
- Publication: 2026-06-15 · INNOMEDIQ
- Merger: type: fusion_by_takeover, proposal_date: 2026-05-29proposed · INNOMEDIQ
- Accounting effect: 2026-01-01proposed · CF-SYSTEM
- Power of attorney: scope: neerlegging en bekendmaking van onderhavig fusievoorstelproposed · INNOMEDIQ
- Power of attorney: scope: neerlegging en bekendmaking van onderhavig fusievoorstelproposed · INNOMEDIQ
- Soil certification: no_real_estateproposed · CF-SYSTEM
- Approval: topic: no_interim_accounts, condition: all_shareholders_consentproposed · INNOMEDIQ
- Act object: Uittreksel voorstel van een met fusie door overneming gelijkgestelde
Summary:
Merger · Accounting effect · Power of attorney · Soil certification
15-06-2026 Merger · Accounting effect · Power of attorney · Soil certification
- Filing: 2026-06-05 · CF-SYSTEM
- Publication: 2026-06-15 · CF-SYSTEM
- Merger: date: 2026-05-29, type: fusion_by_takeoverproposed · INNOMEDIQ
- Accounting effect: 2026-01-01proposed · CF-SYSTEM
- Power of attorney: date: 2026-05-29, role: bijzonder gevolmachtigde, scope: neerlegging en bekendmaking van onderhavig fusievoorstelproposed · CF-SYSTEM
- Power of attorney: date: 2026-05-29, role: bijzonder gevolmachtigde, scope: neerlegging en bekendmaking van onderhavig fusievoorstelproposed · CF-SYSTEM
- Soil certification: no_real_estateproposed · CF-SYSTEM
- Act object: Uittreksel voorstel van een met fusie door overneming gelijkgestelde
Summary:
Merger · Accounting effect · Power of attorney · Soil certification
11-03-2026 3 directors appointed
- CLEAR ROUND BV, Algemeen beheerder
- Bart Windey, Dagelijks bestuur
- Jari Lemmens, Dagelijks bestuur
2025
30-10-2025 Transaction in capital or shares
Summary:
v3.2
2024
11-12-2024 Yves Pauwels appointed as director
2023
10-05-2023 Capital increase of €3,800,000
Summary:
v3.2
2022
02-09-2022 Capital increase of €24,999.20
Summary:
v3.2
06-05-2022 Gert Maris reappointed as statutory auditor
13-01-2022 Capital increase of €324,998.91
Summary:
v3.2
2021
14-06-2021 Transaction in capital or shares
Summary:
v3.2
25-03-2021 Registered office moved from Lubbeek to Tienen
15-03-2021 Incorporation of a new BV
Summary:
oprichting
Analysis
Snowflake analysis
financial profile on 5 axes60
/ 100
Strong profile, led by stability.
Computed on 4 of 5 axes. Not measured: health. An unmeasured axis is not a zero: no data was read for it.
Health
-
Profitability
34
Solvency
65
Growth
48
Stability
94
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soonAI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Credit advice
verdict per customer and amountSimilar
Similar companies
Comparable size, same sectorBE 1010.598.656 · Gent
BE 0778.573.765 · Ledegem
BE 0801.770.326 · Waregem
BE 0472.615.177 · Heusden-Zolder
BE 1003.053.145 · Kapellen
We hold annual accounts for 5,518 of the 24,679 companies in this sector. 740 of them are within a factor 10 of this company's equity.
Company registry
Company registry (CBE)
Crossroads BankActivities
Holdings64200Activiteiten van holdings64210
Primary activity highlighted.
Names & trade names
| Legal nameNL | Hospidex Group |
Registered office
Grijpenlaan 23
3300 Tienen, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.